Literature DB >> 22121032

Phospholipid transfer activity of microsomal triglyceride transfer protein produces apolipoprotein B and reduces hepatosteatosis while maintaining low plasma lipids in mice.

Irani Khatun1, Sebastian Zeissig, Jahangir Iqbal, Minghui Wang, David Curiel, Gregory S Shelness, Richard S Blumberg, M Mahmood Hussain.   

Abstract

UNLABELLED: Microsomal triglyceride transfer protein (MTP), essential for apolipoprotein B (apoB) biosynthesis, evolved as a phospholipid transfer protein and acquired triglyceride transfer activity during a transition from invertebrates to vertebrates. But it is unknown whether MTP directly transfers lipids onto apoB in vivo and, if it does, whether both neutral and polar lipid transfer activities of MTP are critical for lipoprotein assembly. The molecular bases for differences in lipid transfer activities with respect to distinct domains in Drosophila MTP (dMTP) and human MTP (hMTP) are not obvious because both proteins have very similar primary, secondary, and tertiary structures. We used an in vivo approach to delineate physiological significance of these distinct lipid transfer activities by expressing dMTP (transfers phospholipids) and hMTP (transfers phospholipids and triglycerides) orthologs using adenoviruses in liver-specific MTP-deficient (L-MTP(-/-)) mice that have low plasma and high hepatic lipids. Both orthologs improved plasma lipids but plasma triglycerides were lower in dMTP mice due to lower hepatic triglyceride and apoB production. Hepatosteatosis in L-MTP(-/-) mice was ameliorated to similar levels by both. Attenuation of hepatosteatosis upon dMTP expression pertained to enhanced β-oxidation with no changes in lipogenesis. Phospholipid transfer activity of MTP promoted biogenesis of both apoB48 and apoB100-containing very low density lipoprotein in addition to a phospholipid-rich apoB48-containing high-density lipoprotein particle. Triglyceride transfer activity augmented the biosynthesis of triglyceride-rich lipoproteins by increasing the formation of these particles in the lumen of the endoplasmic reticulum.
CONCLUSION: Based on these findings, we posit that the selective inhibition of MTP triglyceride transfer activity might reduce hyperlipidemia while protecting liver from excess lipid accumulation.
Copyright © 2011 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22121032      PMCID: PMC3299931          DOI: 10.1002/hep.25504

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  33 in total

1.  Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice.

Authors:  M Raabe; M M Véniant; M A Sullivan; C H Zlot; J Björkegren; L B Nielsen; J S Wong; R L Hamilton; S G Young
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

Review 2.  Regulation of fatty acid synthesis via phosphorylation of acetyl-CoA carboxylase.

Authors:  D G Hardie
Journal:  Prog Lipid Res       Date:  1989       Impact factor: 16.195

3.  A mechanism of membrane neutral lipid acquisition by the microsomal triglyceride transfer protein.

Authors:  J Read; T A Anderson; P J Ritchie; B Vanloo; J Amey; D Levitt; M Rosseneu; J Scott; C C Shoulders
Journal:  J Biol Chem       Date:  2000-09-29       Impact factor: 5.157

4.  The activity of microsomal triglyceride transfer protein is essential for accumulation of triglyceride within microsomes in McA-RH7777 cells. A unified model for the assembly of very low density lipoproteins.

Authors:  Y Wang; K Tran; Z Yao
Journal:  J Biol Chem       Date:  1999-09-24       Impact factor: 5.157

5.  Transfer of cholesteryl esters and phospholipids as well as net deposition by microsomal triglyceride transfer protein.

Authors:  Paul Rava; Humra Athar; Caroline Johnson; M Mahmood Hussain
Journal:  J Lipid Res       Date:  2005-05-16       Impact factor: 5.922

Review 6.  Regulatory enzymes of mitochondrial beta-oxidation as targets for treatment of the metabolic syndrome.

Authors:  M Schreurs; F Kuipers; F R van der Leij
Journal:  Obes Rev       Date:  2009-08-20       Impact factor: 9.213

7.  Mechanism of microsomal triglyceride transfer protein catalyzed lipid transport.

Authors:  A Atzel; J R Wetterau
Journal:  Biochemistry       Date:  1993-10-05       Impact factor: 3.162

8.  IRE1beta inhibits chylomicron production by selectively degrading MTP mRNA.

Authors:  Jahangir Iqbal; Kezhi Dai; Tracie Seimon; Rivka Jungreis; Miho Oyadomari; George Kuriakose; David Ron; Ira Tabas; M Mahmood Hussain
Journal:  Cell Metab       Date:  2008-05       Impact factor: 27.287

Review 9.  Microsomal triglyceride transfer protein in plasma and cellular lipid metabolism.

Authors:  M Mahmood Hussain; Paul Rava; Xiaoyue Pan; Kezhi Dai; Stephanie K Dougan; Jahangir Iqbal; Farrah Lazare; Irani Khatun
Journal:  Curr Opin Lipidol       Date:  2008-06       Impact factor: 4.776

10.  Microsomal triglyceride transfer protein lipidation and control of CD1d on antigen-presenting cells.

Authors:  Stephanie K Dougan; Azucena Salas; Paul Rava; Amma Agyemang; Arthur Kaser; Jamin Morrison; Archana Khurana; Mitchell Kronenberg; Caroline Johnson; Mark Exley; M Mahmood Hussain; Richard S Blumberg
Journal:  J Exp Med       Date:  2005-08-08       Impact factor: 14.307

View more
  18 in total

Review 1.  Lipotoxicity in the liver.

Authors:  Veronika Zámbó; Laura Simon-Szabó; Péter Szelényi; Eva Kereszturi; Gábor Bánhegyi; Miklós Csala
Journal:  World J Hepatol       Date:  2013-10-27

Review 2.  Lipid transfer proteins in the assembly of apoB-containing lipoproteins.

Authors:  Alaa Sirwi; M Mahmood Hussain
Journal:  J Lipid Res       Date:  2018-04-12       Impact factor: 5.922

3.  Lipid absorption defects in intestine-specific microsomal triglyceride transfer protein and ATP-binding cassette transporter A1-deficient mice.

Authors:  Jahangir Iqbal; John S Parks; M Mahmood Hussain
Journal:  J Biol Chem       Date:  2013-09-09       Impact factor: 5.157

4.  microRNA-30c reduces plasma cholesterol in homozygous familial hypercholesterolemic and type 2 diabetic mouse models.

Authors:  Sara Irani; Jahangir Iqbal; W James Antoni; Laraib Ijaz; M Mahmood Hussain
Journal:  J Lipid Res       Date:  2017-11-09       Impact factor: 5.922

5.  Microsomal Triglyceride Transfer Protein Transfers and Determines Plasma Concentrations of Ceramide and Sphingomyelin but Not Glycosylceramide.

Authors:  Jahangir Iqbal; Meghan T Walsh; Samar M Hammad; Marina Cuchel; Patrizia Tarugi; Robert A Hegele; Nicholas O Davidson; Daniel J Rader; Richard L Klein; M Mahmood Hussain
Journal:  J Biol Chem       Date:  2015-09-08       Impact factor: 5.157

6.  Loss of both phospholipid and triglyceride transfer activities of microsomal triglyceride transfer protein in abetalipoproteinemia.

Authors:  Irani Khatun; Meghan T Walsh; M Mahmood Hussain
Journal:  J Lipid Res       Date:  2013-03-08       Impact factor: 5.922

7.  Novel Abetalipoproteinemia Missense Mutation Highlights the Importance of the N-Terminal β-Barrel in Microsomal Triglyceride Transfer Protein Function.

Authors:  Meghan T Walsh; Jahangir Iqbal; Joby Josekutty; James Soh; Enza Di Leo; Eda Özaydin; Mehmet Gündüz; Patrizia Tarugi; M Mahmood Hussain
Journal:  Circ Cardiovasc Genet       Date:  2015-07-29

8.  MicroRNA-30c Mimic Mitigates Hypercholesterolemia and Atherosclerosis in Mice.

Authors:  Sara Irani; Xiaoyue Pan; Bailey C E Peck; Jahangir Iqbal; Praveen Sethupathy; M Mahmood Hussain
Journal:  J Biol Chem       Date:  2016-06-30       Impact factor: 5.157

9.  Differential impact of hepatic deficiency and total body inhibition of MTP on cholesterol metabolism and RCT in mice.

Authors:  Arne Dikkers; Wijtske Annema; Jan Freark de Boer; Jahangir Iqbal; M Mahmood Hussain; Uwe J F Tietge
Journal:  J Lipid Res       Date:  2014-02-07       Impact factor: 5.922

10.  CD1d-Restricted pathways in hepatocytes control local natural killer T cell homeostasis and hepatic inflammation.

Authors:  Sebastian Zeissig; Kenneth Peuker; Shankar Iyer; Thomas Gensollen; Stephanie K Dougan; Torsten Olszak; Arthur Kaser; Richard S Blumberg
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.